Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Camera vs. needle: study aims to speed up cancer diagnosis in lung fluid patients

NCT ID NCT06892691

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study compares two ways to diagnose cancer in people with fluid buildup around the lungs (pleural effusion). One method, thoracentesis, drains the fluid with a needle. The other, pleuroscopy, uses a tiny camera to look inside and take tissue samples. Researchers want to see which approach gives a clear diagnosis faster and helps patients start cancer treatment sooner. About 98 adults with suspected cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mount Sinai Hospital

    RECRUITING

    New York, New York, 10029, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mount Sinai West

    RECRUITING

    New York, New York, 10019, United States

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this trial succeeds, it could show that pleuroscopy (a camera-guided biopsy) leads to faster cancer diagnosis and treatment than the standard fluid-drainage procedure.

What could go wrong

This is a small, early-stage study (98 people) comparing procedures, not testing a new drug. Results may not apply to all patients, and either procedure carries risks like infection or bleeding.

Conditions

The condition(s) this trial relates to.

neoplasm Pleural Effusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.